Tod Smeal
Tod Smeal publishes mostly in Molecular Biology, Oncology and Pulmonary and Respiratory Medicine, on topics such as Lung Cancer Treatments and Mutations, Chemokine receptors and signaling and Chronic Lymphocytic Leukemia Research.
- World rank
- #96,580 of 7,710,434 ranked researchers
- Rank in United States
- #37,047 of 1,627,098
- Works
- 188
- Citations
- 17k
- Citations per work
- 91.6
What does Tod Smeal research?
Tod Smeal's work is mostly in Medicine (39%), Biochemistry, Genetics and Molecular Biology (35%), Immunology and Microbiology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences7841.4%
- Health Sciences7439.2%
- Medicine7439.2%
- Everything else3619.4%
- 1Molecular Biology31% of their works
- 2Oncology24% of their works
- 3Pulmonary and Respiratory Medicine10% of their works
- 4Immunology6% of their works
- 5Genetics6% of their works
- 6Cell Biology4% of their works
Research topics
Which keywords describe Tod Smeal's research?
The keywords of their largest research topics: Clinical Trials, Targeted Therapy, Therapeutic Targets, Cell Migration, Prognostic Factors, Cancer Therapy, ALK Inhibitors and EGFR Mutations.
- apoptotic cells
- p53
- mTOR
- Signaling
- Protein Kinases
- Genomic Aberrations
- Chemokine Receptors
- EGFR Mutations
- Cancer Therapy
- Cell Migration
- Targeted Therapy
- Clinical Trials
- Therapeutic Targets
- Prognostic Factors
- ALK Inhibitors
- Cancer Metastasis
- Chronic Lymphocytic Leukemia
- Genomic Profiles
- Ras Signaling
- Small-Cell Lung Cancer
- Cell Cycle
- CD47
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Clinical Trials342 topics
- Targeted Therapy342 topics
- Therapeutic Targets342 topics
- Cell Migration322 topics
- Prognostic Factors302 topics
- Cancer Therapy272 topics
- ALK Inhibitors201 topic
- EGFR Mutations201 topic
- Cancer Metastasis181 topic
- Chemokine Receptors181 topic
- Chronic Lymphocytic Leukemia161 topic
- Genomic Aberrations161 topic
- Genomic Profiles141 topic
- Protein Kinases141 topic
- Ras Signaling141 topic
- Signaling141 topic
- Small-Cell Lung Cancer141 topic
- mTOR141 topic
- Cell Cycle131 topic
- p53131 topic
- CD47101 topic
- apoptotic cells101 topic
Where does Tod Smeal work?
Tod Smeal's main affiliation in the publication record is Pfizer (United States), United States.
How many publications and citations does Tod Smeal have?
OpenAlex counts 188 works and 17,213 citations for Tod Smeal, an h-index of 42, ranking #96,580 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Tod Smeal. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.